Quantum Biopharma (QNTM) Amortizatization of Intangibles (2024 - 2026)
Quantum Biopharma recorded quarterly Amortizatization of Intangibles of $13267.0 in Q1 2026, down 1.76% quarter-over-quarter from $13505.0 in Q3 2025, and down 95.96% year-over-year from $328448.0 in Q1 2025.
Quantum Biopharma's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $13267.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 95.96% year-over-year to $13267.0; the TTM figure through Mar 2026 stood at $473831.0 (changed N/A YoY), while the FY2024 annual figure was $14560.0, changed N/A from the prior year.
- Amortizatization of Intangibles came in at $13267.0 for Q1 2026 at Quantum Biopharma, down from $13505.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $328448.0 in Q1 2025 to a low of $13267.0 in Q1 2026.
- A 3-year average of $97678.2 and a median of $14560.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 95.96% in 2026 and fell as far as 95.96% in 2026.
- Quantum Biopharma's Amortizatization of Intangibles stood at $14560.0 in 2024, then fell by 7.25% to $13505.0 in 2025, then declined by 1.76% to $13267.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $13267.0, $13505.0, and $118611.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,267.00 |
| Mar 31, 2026 | 13,267.00 |
| Sep 30, 2025 | 13,505.00 |
| Sep 30, 2025 | 13,505.00 |
| Jun 30, 2025 | 118,611.00 |
| Jun 30, 2025 | 118,611.00 |
| Mar 31, 2025 | 328,448.00 |
| Mar 31, 2025 | 328,448.00 |
| Dec 31, 2024 | 14,560.00 |
| Dec 31, 2024 | 14,560.00 |